Federal Register / Vol. 86, No. 180 / Tuesday, September 21, 2021 / Notices 52479 

Sherrette A. Funn, 

Paperwork Reduction Act Reports Clearance 

Officer, Office of the Secretary. 

[FR Doc. 2021–20324 Filed 9–20–21; 8:45 am] 

BILLING CODE 4150–32–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Tropical Medicine Research 

Centers (U01 Clinical Trial Not Allowed). 

Date: October 18–19, 2021. 

Time: 10:00 a.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G62A, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Eleazar Cohen, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 3G62A, Rockville, MD 

20852, (240) 669–5081, ecohen@

niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: September 15, 2021. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–20370 Filed 9–20–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, National 

Institutes of Health; Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the NIH Clinical Center 

Research Hospital Board. 

The meeting will be held as a virtual 

meeting and open to the public. 

Individuals who plan to view the virtual 

meeting and need special assistance or 

other reasonable accommodations to 

view the meeting should notify the 

Contact Person listed below in advance 

of the meeting. The meeting can be 

accessed from the NIH video https://

videocast.nih.gov/ and the CCRHB 

website https://ccrhb.od.nih.gov/ 

meetings.html. 

Name of Committee: NIH Clinical Center 

Research Hospital Board. 

Date: October 15, 2021. 

Time: 9:00 a.m. to 1:00 p.m. 

Agenda: CC CEO Update, Patient Safety 

and Clinical Quality Update, other business 

of the Board. 

Place: National Institutes of Health, 

Building 1, 9000 Rockville Pike, Bethesda, 

MD 20892 (Virtual Meeting). 

Contact Person: Gretchen Wood, Staff 

Assistant, National Institutes of Health, 

Office of the Director, One Center Drive, 

Building 1, Room 126, Bethesda, MD 20892, 

301–496–4272, woodgs@od.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.14, Intramural Research 

Training Award; 93.22, Clinical Research 

Loan Repayment Program for Individuals 

from Disadvantaged Backgrounds; 93.232, 

Loan Repayment Program for Research 

Generally; 93.39, Academic Research 

Enhancement Award; 93.936, NIH Acquired 

Immunodeficiency Syndrome Research Loan 

Repayment Program; 93.187, Undergraduate 

Scholarship Program for Individuals from 

Disadvantaged Backgrounds, National 

Institutes of Health, HHS) 

Dated: September 15, 2021. 

Patricia B. Hansberger, 

Supervisory Program Analyst, Office of 

Federal Advisory Committee Policy. 

[FR Doc. 2021–20369 Filed 9–20–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health 

(NIMH); Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Interagency Autism 

Coordinating Committee. 

The purpose of the IACC meeting is 

to discuss business, agency updates, and 

issues related to autism spectrum 

disorder (ASD) research and services 

activities. The meeting will be held as 

a virtual meeting and is open to the 

public. Individuals who plan to view 

the virtual meeting and need special 

assistance or other reasonable 

accommodations to view the meeting 

should notify the Contact Person listed 

below at least seven (7) business days in 

advance of the meeting. The open 

session will be videocast and can be 

accessed from the NIH Videocast 

website (http://videocast.nih.gov/). 

Name of Committee: Interagency Autism 

Coordinating Committee (IACC). 

Date: October 13–14, 2021 Meeting 

schedule subject to change. 

Time: 1:00 p.m. to 5:00 p.m. 

Meeting Access: Wednesday, October 13, 

2021 https://videocast.nih.gov/watch=42377 

Thursday, October 14, 2021 https://videocast.

nih.gov/watch=42378. 

Agenda: To discuss business, updates, and 

issues related to ASD research and services 

activities. 

Cost: The meeting is free and open to the 

public. 

Registration: A registration web link will 

be posted on the IACC website 

(www.iacc.hhs.gov) prior to the meeting. Preregistration is recommended. 

Deadlines: Written/Virtual Public 

Comment Due Date: Friday, October 1, 2021, 

by 5:00 p.m. ET, For instructions, see below. 

Contact Person: Ms. Rebecca Martin, Office 

of Autism Research Coordination, National 

Institute of Mental Health, NIH, 6001 

Executive Boulevard, Bethesda, MD 20892– 

9669, Phone: 301–435–0886, Email: 

IACCPublicInquiries@mail.nih.gov. 

Public Comments 

The IACC welcomes public comments 

from members of the autism 

community. As the IACC will be 

updating its Strategic Plan, comments 

related to issues that the community 

would like to see highlighted in the new 

IACC Strategic Plan are welcome. 

Comments may be submitted in writing 

via email to IACCPublicInquiries@

mail.nih.gov or using the web form at: 

https://iacc.hhs.gov/meetings/publiccomments/submit/index.jsp by 5:00 

p.m. ET on Friday, October 1, 2021. A 

limited number of slots are available for 


lotter on DSK11XQN23PROD with NOTICES1